| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Escola Verge, Laura |
| dc.contributor.author | Corona Pérez-Cardona, Pablo Salvador |
| dc.contributor.author | Pigrau Serrallach, Carles |
| dc.contributor.author | Rodríguez Pardo, Ma Dolores |
| dc.date.accessioned | 2021-12-07T13:31:46Z |
| dc.date.available | 2021-12-07T13:31:46Z |
| dc.date.issued | 2021-04 |
| dc.identifier.citation | Escolà-Vergé L, Rodríguez-Pardo D, Corona PS, Pigrau C. Candida Periprosthetic Joint Infection: Is It Curable? Antibiotics. 2021 Apr;10:458. |
| dc.identifier.issn | 2079-6382 |
| dc.identifier.uri | https://hdl.handle.net/11351/6663 |
| dc.description | Fungus; Periprosthetic joint infection; Two-stage exchange surgery |
| dc.description.abstract | Candida periprosthetic joint infection (CPJI) is a rare and very difficult to treat infection, and high-quality evidence regarding the best management is scarce. Candida spp. adhere to medical devices and grow forming biofilms, which contribute to the persistence and relapse of this infection. Typically, CPJI presents as a chronic infection in a patient with multiple previous surgeries and long courses of antibiotic therapy. In a retrospective series of cases, the surgical approach with higher rates of success consists of a two-stage exchange surgery, but the best antifungal treatment and duration of antifungal treatment are still unclear, and the efficacy of using an antifungal agent-loaded cement spacer is still controversial. Until more evidence is available, focusing on prevention and identifying patients at risk of CPJI seems more than reasonable. |
| dc.language.iso | eng |
| dc.publisher | MDPI |
| dc.relation.ispartofseries | Antibiotics;10 |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Candidiasi - Tractament |
| dc.subject | Pròtesis - Complicacions |
| dc.subject.mesh | Candidiasis |
| dc.subject.mesh | /therapy |
| dc.subject.mesh | Prosthesis-Related Infections |
| dc.title | Candida Periprosthetic Joint Infection: Is It Curable? |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.3390/antibiotics10040458 |
| dc.subject.decs | candidiasis |
| dc.subject.decs | /terapia |
| dc.subject.decs | infecciones relacionadas con prótesis |
| dc.relation.publishversion | https://doi.org/10.3390/antibiotics10040458 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Escolà-Vergé L, Rodríguez-Pardo D, Pigrau C] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, 28029 Madrid, Spain. Study Group on Osteoarticular Infections of the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIO-SEIMC), 28003 Madrid, Spain. [Corona PS] Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, 28029 Madrid, Spain. Study Group on Osteoarticular Infections of the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIO-SEIMC), 28003 Madrid, Spain. Unitat de Cirurgia Sèptica i Reconstructiva, Servei de Cirurgia Ortopèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
| dc.identifier.pmid | 33920619 |
| dc.identifier.wos | 000642704600001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |